(Q36176008)

English

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

attention deficit hyperactivity disorder

1 reference

based on heuristic

inferred from title

author name string

Gabrielle A Carlson

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

David Dunn

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Douglas Kelsey

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dustin Ruff

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Susan Ball

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Lisa Ahrbecker

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Albert J Allen

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

27 September 2007

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Child and Adolescent Psychiatry and Mental Health

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

27 September 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

1 October 2017

Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

1 October 2017

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

1 October 2017

Concomitant psychotropic medication for youths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

1 October 2017

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

1 October 2017

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

1 October 2017

Rating scales and checklists for child psychopharmacology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

2 July 2018

Hemodynamic effects of acute administration of atomoxetine and methylphenidate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

23 September 2018

Neurobiology of attention-deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2098748

23 September 2018

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Con

1 reference

https://pubmed.ncbi.nlm.nih.gov/17897473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side effects of methylphenidate and desipramine alone and in combination in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17897473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National trends in concomitant psychotropic medication with stimulants in pediatric visits: practice versus knowledge

1 reference

https://pubmed.ncbi.nlm.nih.gov/17897473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17897473

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1753-2000-1-10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36176008&oldid=2198301111"